Changes in the peripheral blood T-Cell receptor V beta repertoire in vivo and in vitro during shigellosis
- PMID: 8606106
- PMCID: PMC173931
- DOI: 10.1128/iai.64.4.1391-1399.1996
Changes in the peripheral blood T-Cell receptor V beta repertoire in vivo and in vitro during shigellosis
Abstract
A sequential activation of T cells in peripheral blood during shigello sis has been observer (D. Islam, P.K. Bradham, A. A. Lindberg, and B. Christensson, Infect. Immun 63:2941-2949, 1995). To further investigate the cellular response during the course of Shigella infection, changes in the T-cell receptor (TCR) repertoire in the subsets in blood in patients during shigellosis was that Shigella antigens may modulate the function of T cells carrying TCRs capable of recognizing Shigella-specific epitopes or superantigens. Such a selective preference for T cells expressing certain TCR Vbeta types could lead to the expansion or deletion of these T cells. In the present study of 27 adult male Bangladeshi patients with dysentery (14 cases caused by Shigella Dysenteriae 1 and 13 cases caused by Shigella flexneri), the changes in the TCR Vbeta repertoire of peripheral blood CD4+ and CD8+ T-cell subsets have been analyzed with a panel of nine anti-Vbeta monoclonal antibodies by flow cytometry. Twenty healthy males from Bangladesh and 20 healthy males from Sweden served as controls. Compared with the Bangladeshi controls, the patients had an increased frequency of CD4+T cells expression Vbeta2, Vbeta3, and Vbeta17, with a maximum at day 7 after the onset of disease. The frequency of CD4+T cells expressing Vbeta5.1 was increased only in patients with S. flexneri infection. Peripheral blood T cells from Shigella-infected patients also responded to in vitro stimulation in a TCR Vbeta-specific manner. Stimulation with heat-killed S. dysenteriae 1 and Shiga toxin enhanced the frequency of cells expressing Vbeta2, Vbeta3, Vbeta5.1, Vbeta13.6, and Vbeta17, especially in samples obtained at day 7. The enhanced frequency of cells expressing Vbeta2, Vbeta3, Vbeta5.1, and Vbeta17 found both in in vivo and in vitro could suggest that in shigellosis antigens or superantigens are presented to the immune system and preferentially activate certain TCR Vbeta types in T-cell subsets. The kinetics of the change in the TCR Vbeta repertoire in blood during shigellosis may indicate that following local activation, the antigen activated T cells can be retrieved in the blood and restimulated in vitro. If confirmed by parallel analysis of T cells in the gut and blood by TCR sequence analysis, the possibility suggested by our findings would facilitate further analysis of the role of cell-mediated immune responses in the pathogenesis of and protection against Shigella infection.
Similar articles
-
Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease.Infect Immun. 1995 Aug;63(8):2941-9. doi: 10.1128/iai.63.8.2941-2949.1995. Infect Immun. 1995. PMID: 7622216 Free PMC article.
-
[Analyses of subset, activated state and expression pattern of 24 repertoire TCR Vbeta of peripheral blood T lymphocytes in convalescence patients with severe acute respiratory syndrome (SARS)].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Jan;21(1):114-7. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005. PMID: 15629099 Chinese.
-
T cell activation by coxsackievirus B4 antigens in type 1 diabetes mellitus: evidence for selective TCR Vbeta usage without superantigenic activity.J Immunol. 2001 Sep 15;167(6):3513-20. doi: 10.4049/jimmunol.167.6.3513. J Immunol. 2001. PMID: 11544345
-
T cell activation profiles in Kawasaki syndrome.Clin Exp Immunol. 2008 Feb;151(2):267-74. doi: 10.1111/j.1365-2249.2007.03567.x. Epub 2007 Dec 6. Clin Exp Immunol. 2008. PMID: 18070150 Free PMC article.
-
Disease-dependent changes in T-cell populations in patients with shigellosis.APMIS. 2000 Apr;108(4):251-60. doi: 10.1034/j.1600-0463.2000.d01-52.x. APMIS. 2000. PMID: 10843411
Cited by
-
Persistence of mucosal mast cells and eosinophils in Shigella-infected children.Infect Immun. 2003 May;71(5):2684-92. doi: 10.1128/IAI.71.5.2684-2692.2003. Infect Immun. 2003. PMID: 12704143 Free PMC article.
-
Adaptive immune responses during Shigella dysenteriae type 1 infection: an in vitro stimulation with 57 kDa major antigenic OMP in the presence of anti-CD3 antibody.Mol Cell Biochem. 2010 May;338(1-2):1-10. doi: 10.1007/s11010-009-0314-z. Epub 2009 Nov 14. Mol Cell Biochem. 2010. PMID: 19915959
-
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.Nat Rev Microbiol. 2007 Jul;5(7):540-53. doi: 10.1038/nrmicro1662. Nat Rev Microbiol. 2007. PMID: 17558427 Free PMC article. Review.
-
A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.PLoS One. 2018 Jan 5;13(1):e0189571. doi: 10.1371/journal.pone.0189571. eCollection 2018. PLoS One. 2018. PMID: 29304144 Free PMC article.
-
Parameters underlying successful protection with live attenuated mutants in experimental shigellosis.Infect Immun. 2001 Feb;69(2):1072-83. doi: 10.1128/IAI.69.2.1072-1083.2001. Infect Immun. 2001. PMID: 11160004 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials